| Pharmacology of cardiac potassium channels J Tamargo, R Caballero, R Gómez, C Valenzuela, E Delpón Cardiovascular research 62 (1), 9-33, 2004 | 613 | 2004 |
| Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes C Valenzuela, DJ Snyders, PB Bennett, J Tamargo, LM Hondeghem Circulation 92 (10), 3014-3024, 1995 | 279 | 1995 |
| Stereoselective block of a human cardiac potassium channel (Kv1. 5) by bupivacaine enantiomers C Valenzuela, E Delpon, MM Tamkun, J Tamargo, DJ Snyders Biophysical Journal 69 (2), 418-427, 1995 | 229 | 1995 |
| ω-3 and ω-6 polyunsaturated fatty acids block HERG channels M Guizy, C Arias, M David, T González, C Valenzuela American Journal of Physiology-Cell Physiology 289 (5), C1251-C1260, 2005 | 194 | 2005 |
| On the Molecular Nature of the Lidocaine Receptor of Cardiac Na+ Channels: Modification of Block by Alterations in the α-Subunit III-IV Interdomain PB Bennett, C Valenzuela, LQ Chen, RG Kallen Circulation research 77 (3), 584-592, 1995 | 141 | 1995 |
| Molecular determinants of stereoselective bupivacaine block of hKv1. 5 channels L Franqueza, M Longobardo, J Vicente, E Delpón, MM Tamkun, ... Circulation Research 81 (6), 1053-1064, 1997 | 112 | 1997 |
| Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences N Villalonga, M David, J Bielanska, R Vicente, N Comes, C Valenzuela, ... Journal of General Physiology 135 (2), 135-147, 2010 | 111 | 2010 |
| Losartan and Its Metabolite E3174 Modify Cardiac Delayed Rectifier K+ Currents R Caballero, E Delpón, C Valenzuela, M Longobardo, J Tamargo Circulation 101 (10), 1199-1205, 2000 | 111 | 2000 |
| Class III antiarrhythmic effects of zatebradine: time-, state-, use-, and voltage-dependent block of hKv1. 5 channels C Valenzuela, E Delpo´ n, L Franqueza, P Gay, O Pe´ rez, J Tamargo, ... Circulation 94 (3), 562-570, 1996 | 110 | 1996 |
| Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization I Moreno, R Caballero, T González, C Arias, C Valenzuela, I Iriepa, ... Journal of Pharmacology and Experimental Therapeutics 304 (2), 862-873, 2003 | 99 | 2003 |
| Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1. 3 voltage-dependent potassium channels N Villalonga, M David, J Bielańska, T González, D Parra, C Soler, ... Biochemical pharmacology 80 (6), 858-866, 2010 | 88 | 2010 |
| Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go–related gene channels R Caballero, I Moreno, T González, C Arias, C Valenzuela, E Delpón, ... Circulation 107 (6), 889-895, 2003 | 86 | 2003 |
| Effects of ropivacaine on a potassium channel (hKv1. 5) cloned from human ventricle C Valenzuela, E Delpon, L Franqueza, P Gay, DJ Snyders, J Tamargo The Journal of the American Society of Anesthesiologists 86 (3), 718-728, 1997 | 84 | 1997 |
| Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block T González, C Arias, R Caballero, I Moreno, E Delpón, J Tamargo, ... British journal of pharmacology 137 (8), 1269-1279, 2002 | 78 | 2002 |
| Effects of propafenone and 5-hydroxy-propafenone on hKv1. 5 channels L Franqueza, C Valenzuela, E Delpón, M Longobardo, R Caballero, ... British journal of pharmacology 125 (5), 969, 1998 | 78 | 1998 |
| Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease JR Naranjo, H Zhang, D Villar, P González, XM Dopazo, J Morón-Oset, ... The Journal of clinical investigation 126 (2), 627-638, 2016 | 74 | 2016 |
| Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current R Caballero, R Gómez, I Moreno, L Nuñez, T González, C Arias, M Guizy, ... Cardiovascular research 62 (1), 86-95, 2004 | 68 | 2004 |
| Modulation of the atrial specific Kv1. 5 channel by the n-3 polyunsaturated fatty acid, α-linolenic acid M Guizy, M David, C Arias, L Zhang, M Cofán, V Ruiz-Gutiérrez, E Ros, ... Journal of molecular and cellular cardiology 44 (2), 323-335, 2008 | 67 | 2008 |
| A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome C Moreno, A Oliveras, A De La Cruz, C Bartolucci, C Munoz, E Salar, ... Cardiovascular Research 107 (4), 613-623, 2015 | 65 | 2015 |
| Cell cycle-dependent expression of Kv1. 5 is involved in myoblast proliferation N Villalonga, R Martínez-Mármol, M Roura-Ferrer, M David, C Valenzuela, ... Biochimica et biophysica acta (BBA)-molecular cell research 1783 (5), 728-736, 2008 | 63 | 2008 |
Juan TamargoUniversidad Complutense de MadridVerified email at med.ucm.es
